Radiation
TLI
TLI is a radiation therapy with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
RADIATION
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Active, not recruiting1
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (66.7%)
Phase 21 (33.3%)
Trials by Status
active_not_recruiting133%
withdrawn133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_2
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
NCT00882895
recruitingphase_1
Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta
NCT05950802
withdrawnphase_1
Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah
NCT06003179
Clinical Trials (3)
Showing 3 of 3 trials
NCT00882895Phase 2
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
NCT05950802Phase 1
Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta
NCT06003179Phase 1
Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah
All 3 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 3